Bio Pharma Dive
JANUARY 28, 2025
The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ahead of chemotherapy in a variety of tumors.
Pharmaceutical Technology
JANUARY 28, 2025
AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise Tadekinig alfa.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 28, 2025
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.
Pharmaceutical Technology
JANUARY 28, 2025
the company announced that its Phase III trial examining its gastroenteropancreatic tumour treatment, ITM-11, met its primary endpoint.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
JANUARY 28, 2025
ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of neuroendocrine tumor.
Pharmaceutical Technology
JANUARY 28, 2025
A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 28, 2025
Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.
Pharma Times
JANUARY 28, 2025
Patients and care partners may find once every four weeks maintenance dosing easier
Pharmaceutical Technology
JANUARY 28, 2025
Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.
pharmaphorum
JANUARY 28, 2025
Bring your waiting experience to life with Virtual Reality (VR)! Discover how VR technology is revolutionising the way we pass the time and enhancing customer satisfaction.
Pharmaceutical Technology
JANUARY 28, 2025
Arena Internationals Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and regulatory shifts.
Pharma Times
JANUARY 28, 2025
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25
Pharmaceutical Technology
JANUARY 28, 2025
Sages board of directors said that the proposal significantly undervalues the company and is not in the best interest of shareholders.
pharmaphorum
JANUARY 28, 2025
Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharmaceutical Technology
JANUARY 28, 2025
This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.
pharmaphorum
JANUARY 28, 2025
Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.
Pharmaceutical Technology
JANUARY 28, 2025
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme.
ACRP blog
JANUARY 28, 2025
Collection of sensitive personal data is a cornerstone of clinical research involving drugs and medical devices. However, if the personal data relates to European Union (EU) or United Kingdom (UK) residents, this raises particular legal and compliance issues due to the General Data Protection Regulation (GDPR). Securing, anonymizing, and transferring personal data is complex and challenging in these regions, especially when there is a need to share personal data with vendors and research partner
Outsourcing Pharma
JANUARY 28, 2025
Novo Nordisks amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lillys Zepbound. Further trials are planned.
pharmaphorum
JANUARY 28, 2025
Enhertu gets much-anticipated new FDA approval in breast cancer that expands its label and makes it an earlier option in the treatment pathway.
Outsourcing Pharma
JANUARY 28, 2025
Throughout her career, One2Treats milie Barr has focused on developing both the analytical and leadership aspects necessary for success in the field.
pharmaphorum
JANUARY 28, 2025
Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
JANUARY 28, 2025
Manas AI secures funding led by General Catalyst to scale AI-driven drug discovery, tackling cancer and rare diseases.
pharmaphorum
JANUARY 28, 2025
Watch the exclusive video interview of Tran Le and Sohit Gatiganti discussing JPM 2025 and their insights into the future of technology and innovation.
Pharmaceutical Commerce
JANUARY 28, 2025
A study explores dual-enrollment in these planscompared to other Medicare Advantage plans impacts North Carolinas Medicaid fee-for-service spending.
BioPharma Reporter
JANUARY 28, 2025
Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast growth factor 21 analog, designed to treat patients with biopsy-confirmed compensated cirrhosis due to MASH.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
JANUARY 28, 2025
Craft authentic connections by design with digital content that resonates. Develop strategies, create engaging content, and build trust with your audience. Explore the power of content in crafting authentic connections.
Pharmaceutical Commerce
JANUARY 28, 2025
Donald Prentiss discusses the value of these pharmacies, especially during shortages.
pharmaphorum
JANUARY 28, 2025
Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.
Pharmaceutical Commerce
JANUARY 28, 2025
The latest news for pharma industry insiders.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
200 
Let's personalize your content